Malaria immunization in Rhesus monkeys. A vaccine effective against both the sexual and asexual stages of Plasmodium knowlesi
- PMID: 102724
- PMCID: PMC2185060
- DOI: 10.1084/jem.148.5.1311
Malaria immunization in Rhesus monkeys. A vaccine effective against both the sexual and asexual stages of Plasmodium knowlesi
Abstract
Rhesus monkeys were immunized with a preparation of Plasmodium knowlesi parasites containing principally microgametes with lesser numbers of macrogametes and asexual trophozoites. The antigen mixture was emulsified in Freund's complete adjuvant (FCA) and administered intramuscularly. After one or two inoculations of from 10(5) to 10(7) microgametes in FCA, monkeys showed high levels of circulating anti-gamete antibodies as demonstrated by various in vitro microgamete immobilization or transmission blocking tests. After challenge with P. knowlesi, immunized monkeys developed low level asexual parasitemias and were not infectious to feeding mosquitoes as measured by growth of the parasite on the mosquito gut. Control monkeys developed rapidly rising, usually fatal infections and were highly infectious to mosquitoes. Anti-gamete antibodies appear to neutralize the sexual parasites and prevent mosquito infection within the gut of the recently fed mosquito vector. Suppression of asexual parasitemia in immunized monkeys may be due to the presence of asexual trophozoites in the antigen mixture or to antigens common to both sexual and asexual stages of the parasite. A vaccine effective as a single injection capable of interrupting malaria transmission from man to man whereas reducing the severity of the disease in infected individuals offers a new approach to the control of one of the major diseases affecting man.
Similar articles
-
Plasmodium knowlesi: persistence of transmission blocking immunity in monkeys immunized with gamete antigens.Infect Immun. 1984 Apr;44(1):137-40. doi: 10.1128/iai.44.1.137-140.1984. Infect Immun. 1984. PMID: 6706402 Free PMC article.
-
Vaccination of Rhesus monkeys (Macaca mulatta) against Plasmodium knowlesi by the use of nonviable antigen.Bull World Health Organ. 1973 May;48(5):597-604. Bull World Health Organ. 1973. PMID: 4204492 Free PMC article.
-
Merozoite vaccination against Plasmodium knowlesi malaria.Immunology. 1975 Aug;29(2):397-407. Immunology. 1975. PMID: 1158390 Free PMC article.
-
Protective antigens of bloodstage Plasmodium knowlesi parasites.Philos Trans R Soc Lond B Biol Sci. 1984 Nov 13;307(1131):159-69. doi: 10.1098/rstb.1984.0116. Philos Trans R Soc Lond B Biol Sci. 1984. PMID: 6151680 Review.
-
The emerging of the fifth malaria parasite (Plasmodium knowlesi): a public health concern?Braz J Infect Dis. 2010 May-Jun;14(3):299-309. Braz J Infect Dis. 2010. PMID: 20835518 Review.
Cited by
-
Acquired immunity to malaria.Clin Microbiol Rev. 2009 Jan;22(1):13-36, Table of Contents. doi: 10.1128/CMR.00025-08. Clin Microbiol Rev. 2009. PMID: 19136431 Free PMC article. Review.
-
Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans.Infect Immun. 1987 Feb;55(2):369-72. doi: 10.1128/iai.55.2.369-372.1987. Infect Immun. 1987. PMID: 2879793 Free PMC article.
-
Effect of polyclonal anti-procyclic antibodies on development of Trypanosoma brucei brucei in tsetse flies.Parasitol Res. 1991;77(1):39-43. doi: 10.1007/BF00934382. Parasitol Res. 1991. PMID: 1994370
-
Why not vaccinate against malaria?Br Med J (Clin Res Ed). 1981 May 23;282(6277):1650-1. Br Med J (Clin Res Ed). 1981. PMID: 6786415 Free PMC article. No abstract available.
-
Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito.J Exp Med. 1985 Nov 1;162(5):1460-76. doi: 10.1084/jem.162.5.1460. J Exp Med. 1985. PMID: 2865324 Free PMC article.